Skip to main content


Page 3 of 68

  1. Metabolic dysfunction-associated steatotic liver disease (MASLD) is the leading cause of chronic liver disease that affects over 30% of the world’s population. For decades, the heterogeneity of non-alcoholic f...

    Authors: Yuxiao Jiang, Lili Wu, Xiaopeng Zhu, Hua Bian, Xin Gao and Mingfeng Xia
    Citation: Lipids in Health and Disease 2024 23:95
  2. Circulating ceramide (Cer) drives various pathological processes associated with cardiovascular diseases, liver illness, and diabetes mellitus. Although recognized as predictors of cardiometabolic diseases (CM...

    Authors: Youssef M. Shalaby, Bashar Al-Zohily, Anjana Raj, Javed Yasin, Sania Al Hamad, Charalambos Antoniades, Nadia Akawi and Elhadi H. Aburawi
    Citation: Lipids in Health and Disease 2024 23:93
  3. Lipoprotein lipase (LPL) plays a crucial role in triglyceride hydrolysis. Rare biallelic variants in the LPL gene leading to complete or near-complete loss of function cause autosomal recessive familial chylomicr...

    Authors: Yuepeng Hu, Jian-Min Chen, Han Zuo, Na Pu, Guofu Zhang, Yichen Duan, Gang Li, Zhihui Tong, Weiqin Li, Baiqiang Li and Qi Yang
    Citation: Lipids in Health and Disease 2024 23:92
  4. β-Propeller protein-associated neurodegeneration (BPAN) is a genetic neurodegenerative disease caused by mutations in WDR45. The impairment of autophagy caused by WDR45 deficiency contributes to the pathogenesis ...

    Authors: Qiuhong Xiong, Huimin Sun, Yanlin Wang, Qian Xu, Yu Zhang, Mei Xu, Zhonghua Zhao, Ping Li and Changxin Wu
    Citation: Lipids in Health and Disease 2024 23:91
  5. Blood stasis constitution in traditional Chinese medicine (TCM) is believed to render individuals more susceptible to metabolic diseases. However, the biological underpinnings of this constitutional imbalance ...

    Authors: Chen Sun, Yanmin Liu, Wei Huang, Yang Chen, Yusheng Deng, Jiamin Yuan, Lili Deng, Ning Xu, Xiaoxiao Shang, Chuyang Wang, Zhimin Yang, Li Huang and Qinwei Qiu
    Citation: Lipids in Health and Disease 2024 23:90
  6. Current research has suggested that asialoglycoprotein receptor 1 (ASGR1) is involved in cholesterol metabolism and is also related to systemic inflammation. This study aimed to assess the correlation between ...

    Authors: Qin Luo, Jingfei Chen, Yanfeng Yi, Panyun Wu, Yingjie Su, Zhangling Chen, Hacı Ahmet Aydemir, Jianjun Tang, Zhenfei Fang and Fei Luo
    Citation: Lipids in Health and Disease 2024 23:89
  7. The accumulation of reactive oxygen species (ROS) within the bone marrow microenvironment leads to diminished osteogenic differentiation and heightened lipogenic differentiation of mesenchymal stem cells resid...

    Authors: Jinying Li, Yongshao Chen, Dingsheng Zha, Chunhui Wu, Xiaofen Li, Li Yang, Hui Cao, Shexing Cai and Yuebo Cai
    Citation: Lipids in Health and Disease 2024 23:88
  8. This study aimed to investigate the association between the triglyceride-glucose (TyG) index in early pregnancy and the development of gestational diabetes mellitus (GDM) in the second trimester. The primary o...

    Authors: Yufeng Guo, Junwen Lu, Mailiman Bahani, Guifeng Ding, Lei Wang, Yuxia Zhang, Huanmei Zhang, Chengyao Liu, Lijun Zhou, Xiaolan Liu, Fangshen Li, Xiaoli Wang and Hong Ding
    Citation: Lipids in Health and Disease 2024 23:87

    The Correction to this article has been published in Lipids in Health and Disease 2024 23:132

  9. Acute myocardial infarction (AMI) is characterized by inflammation, oxidative stress, and atherosclerosis, contributing to increased mortality risk. High-density lipoprotein (HDL) takes a crucial part in mitig...

    Authors: Congzhuo Jia, Wanying Wu, Huan Lu, Jin Liu, Shiqun Chen, Guoxiao Liang, Yang Zhou, Sijia Yu, Linfang Qiao, Jinming Chen, Ning Tan, Yong Liu and Jiyan Chen
    Citation: Lipids in Health and Disease 2024 23:86
  10. Familial hypercholesterolemia (FH) is a prevalent hereditary disease that can cause aberrant cholesterol metabolism. In this study, we confirmed that c.415G > A in low-density lipoprotein receptor (LDLR), an FH-r...

    Authors: Kaihan Wang, Tingting Hu, Mengmeng Tai, Yan Shen, Haocheng Chai, Shaoyi Lin and Xiaomin Chen
    Citation: Lipids in Health and Disease 2024 23:85
  11. Sodium-glucose cotransporter 2 (SGLT2) inhibition is recognized for its evident renoprotective benefits in diabetic renal disease. Recent data suggest that SGLT2 inhibition also slows down kidney disease progr...

    Authors: Zhijuan Wang, Jie Wei, Wenman Zhao, Rui Shi, Yuyu Zhu, Xunliang Li and Deguang Wang
    Citation: Lipids in Health and Disease 2024 23:84
  12. To enhance the detection, management and monitoring of Chinese children afflicted with sitosterolemia by examining the physical characteristics and genetic makeup of pediatric patients.

    Authors: Rui Gu, Hui Wang, Chun-Lin Wang, Mei Lu, Miao Miao, Meng-Na Huang, Yi Chen, Yang-Li Dai, Ming-Qiang Zhu, Qiong Zhou and Chao-Chun Zou
    Citation: Lipids in Health and Disease 2024 23:83
  13. Dyslipidemia and abnormalities in cholesterol metabolism are commonly observed in individuals with gallstone disease. Previous research has demonstrated that dietary magnesium can influence lipid metabolism. T...

    Authors: Wenyi Du, Chen Yan, Yinkang Wang, Chen Song, Yunfan Li, Zhiqiang Tian, Yuan Liu and Wei Shen
    Citation: Lipids in Health and Disease 2024 23:82
  14. Obesity is associated with extensive white adipose tissue (WAT) expansion and remodeling. Healthy WAT expansion contributes to the maintenance of energy balance in the liver, thereby ameliorating obesity-relat...

    Authors: Tao Yao, Danni Wei, Xin Tian, Lin Zhao, Qiangyou Wan, Xiaoli Zhang, Juan Cai, Siqi Li, Bowen Diao, Suihan Feng, Bo Shan, Mengle Shao and Ying Wu
    Citation: Lipids in Health and Disease 2024 23:81
  15. The study aimed to investigate the association between nonalcoholic fatty liver disease (NAFLD) and ischemic stroke events after revascularization in patients with Moyamoya disease (MMD).

    Authors: Bojian Zhang, Junsheng Li, Chaofan Zeng, Chuming Tao, Qiheng He, Chenglong Liu, Zhiyao Zheng, Zhikang Zhao, Siqi Mou, Wei Sun, Jia Wang, Qian Zhang, Rong Wang, Yan Zhang, Peicong Ge and Dong Zhang
    Citation: Lipids in Health and Disease 2024 23:80
  16. Insulin resistance (IR) imposes a significant burden on inflammatory diseases, and the triglyceride-glucose (TyG) index, which is an easily accessible indicator for detecting IR, holds great application potent...

    Authors: Yang Liu, Junjie Yao, Xiaona Xue, Yanan Lv, Sheng Guo and PeiDong Wei
    Citation: Lipids in Health and Disease 2024 23:79
  17. In observational studies, there exists an association between obesity and epigenetic age as well as telomere length. However, varying and partially conflicting outcomes have notably arisen from distinct studie...

    Authors: Jixin Li, Wenru Wang, Zhenyu Yang, Linjie Qiu, Yan Ren, Dongling Wang, Meijie Li, Wenjie Li, Feng Gao and Jin Zhang
    Citation: Lipids in Health and Disease 2024 23:78
  18. Obesity is associated with elevated serum uric acid (SUA) levels and frequent gout flares. Losing weight can reduce the SUA level and gout flares. The effect of orlistat on SUA levels and gout flares in patien...

    Authors: Shuang Liu, Xiaojing Lin, Minghao Tao, Qi Chen, Hang Sun, Yali Han, Shaoling Yang, Yining Gao, Shen Qu and Haibing Chen
    Citation: Lipids in Health and Disease 2024 23:77
  19. Atherosclerosis (AS) is a persistent inflammatory condition triggered and exacerbated by several factors including lipid accumulation, endothelial dysfunction and macrophages infiltration. Nobiletin (NOB) has ...

    Authors: Heng Wang, Qinqin Tian, Ruijing Zhang, Qiujing Du, Jie Hu, Tingting Gao, Siqi Gao, Keyi Fan, Xing Cheng, Sheng Yan, Guoping Zheng and Honglin Dong
    Citation: Lipids in Health and Disease 2024 23:76
  20. The association between remnant cholesterol (RC) and diabetic retinopathy (DR) in type 2 diabetes mellitus (T2DM) remains unclear. Morphological changes in retinal vessels have been reported to predict vascula...

    Authors: Shuli Chen, Yi Xu, Bo Chen, Senlin Lin, Lina Lu, Minna Cheng, Yuheng Wang, Qinping Yang, Saiguang Ling, Dengji Zhou, Yan Shi, Haidong Zou and Yingyan Ma
    Citation: Lipids in Health and Disease 2024 23:75
  21. Direct-acting Antiviral Agents (DAAs) influence serum lipids of patients with Hepatitis C virus (HCV). This paper presents an analysis of the relevant literature to investigate the effects of DAAs in treating ...

    Authors: Tingting Mei, Xiaojie Huang, Shan Tang, Menglu Liu, Wenyan Zhang and Haibin Yu
    Citation: Lipids in Health and Disease 2024 23:74
  22. Prediabetes is a high-risk state for diabetes, and numerous studies have shown that the body mass index (BMI) and triglyceride-glucose (TyG) index play significant roles in risk prediction for blood glucose me...

    Authors: Hongyi Yang, Maobin Kuang, Jiajun Qiu, Shiming He, Changhui Yu, Guotai Sheng and Yang Zou
    Citation: Lipids in Health and Disease 2024 23:71
  23. The incidence of hyperlipidemic acute pancreatitis (HLAP) has been increasing annually. However, population-based morbidity assessments need to be updated. Early, rapid, and effective lipid-lowering may minimi...

    Authors: Weidong Zhou, Qinfu Liu, Zhaojun Wang, Liying Yao, Jian Chen and Xiaojun Yang
    Citation: Lipids in Health and Disease 2024 23:70
  24. Chronic stress and diabetes mellitus are highly associated with oxidative stress and inflammation, resulting in cell membrane disruption and platelet activity. This study aims to evaluate the impact of chronic...

    Authors: Inga Bikulčienė, Justinas Baleišis, Eglė Mazgelytė, Romualdas Rudys, Rūta Vosyliūtė, Renata Šimkūnaitė-Rizgelienė, Arvydas Kaminskas and Dovilė Karčiauskaitė
    Citation: Lipids in Health and Disease 2024 23:69
  25. Stress is implicated in various pathological conditions leading to liver injury. Existing evidence suggests that excessive stress can induce mitochondrial damage in hepatocytes, yet the underlying mechanism re...

    Authors: Yichang Liu, Zhaoling Sun, Qiuli Sun, Li Wang, Chuan Wang, Yingmin Li, Chunling Ma, Weibo Shi, Guozhong Zhang, Yiming Dong, Xiaojing Zhang and Bin Cong
    Citation: Lipids in Health and Disease 2024 23:68
  26. Whether iron intake can affect cardiovascular disease (CVD) and dyslipidemia is controversial. However, few studies have focused on reducing the risk of CVD in people at risk for dyslipidemia. This study explo...

    Authors: Min Cui, Hao Wu, Hanmo Zhang, Liping Wei and Xin Qi
    Citation: Lipids in Health and Disease 2024 23:67
  27. Cardiovascular disease (CVD) is associated with inflammation and abnormal lipid metabolism. However, a single inflammatory index or a single lipid index cannot accurately predict the prognosis of CVD independe...

    Authors: Yu Gao, Miyuan Wang, Ruiting Wang, Jinchi Jiang, Yueyao Hu, Wei Wang, Yong Wang and Haijing Li
    Citation: Lipids in Health and Disease 2024 23:66
  28. Active tuberculosis (TB) significantly increases the risk of cardiovascular disease, but the underlying mechanisms remain unclear. This study aimed to investigate the association between inflammation biomarker...

    Authors: Joseph Baruch Baluku, Robinah Nalwanga, Andrew Kazibwe, Ronald Olum, Edwin Nuwagira, Nathan Mugenyi, Frank Mulindwa and Felix Bongomin
    Citation: Lipids in Health and Disease 2024 23:65
  29. Extensive evidence demonstrates correlations among gut microbiota, lipid metabolism and cognitive function. However, there is still a lack of researches in the field of late-life depression (LLD). This researc...

    Authors: Yan Chen, Jiarong Li, Dansheng Le, Yuhan Zhang and Zhengluan Liao
    Citation: Lipids in Health and Disease 2024 23:64
  30. Dyslipidemia is significantly more common in those with concurrent chronic kidney disease (CKD) and chronic heart failure (CHF). Sacubitril/valsartan has showcased its influence on both cardiac and renal funct...

    Authors: Manzhi Li, Ao Zhong, Yifan Tang, Jinnuo Yu, Mengmeng Wu, Karthick Kumaran Munisamy Selvam and Dong Sun
    Citation: Lipids in Health and Disease 2024 23:63
  31. To investigate the baseline and six-month follow-up data of the main lipid indices as well as low-density lipoprotein cholesterol (LDL-C) target goal attainment in accordance with the current guidelines among ...

    Authors: Zhong Chen, Shijia Jin and Yifan Zhang
    Citation: Lipids in Health and Disease 2024 23:62
  32. The roles of serum lipids on digestive system cancer (DSC) risk were still inconclusive. In this study, we systematically assessed indicative effects of signature lipidomic biomarkers (high-density lipoprotein...

    Authors: Yuanlin Sun, Donghui Cao, Yang Zhang, Yanhua Wu, Zhifang Jia, Yingnan Cui, Dongming Li, Xueyuan Cao and Jing Jiang
    Citation: Lipids in Health and Disease 2024 23:61
  33. Cancer cells need constant supplies of lipids to survive and grow. Lipid dependence has been observed in various types of cancer, including high-grade serous ovarian carcinomas (HGSOC), which is a lethal form ...

    Authors: Emilie Wong Chong, France-Hélène Joncas, Pierre Douville, Dimcho Bachvarov, Caroline Diorio, Frédéric Calon, Ann-Charlotte Bergeron, Jonatan Blais, Shuk On Annie Leung, Nabil Georges Seidah and Anne Gangloff
    Citation: Lipids in Health and Disease 2024 23:59
  34. Non-alcoholic fatty liver disease (NAFLD) patients have exhibited extra-hepatic neurological changes, but the causes and mechanisms remain unclear. This study investigates the causal effect of NAFLD on cortica...

    Authors: Zun Mao, Zhi-xiang Gao, Tong Ji, Sheng Huan, Guo-ping Yin and Long Chen
    Citation: Lipids in Health and Disease 2024 23:58
  35. The sneaky onset and dismal prognosis of chronic kidney disease (CKD) make it an important public health issue. Obesity-related kidney illness has garnered more attention in recent times. Establishing and vali...

    Authors: Haixia Zhang, Yue Zhang, Wenxing Gao and Yiming Mu
    Citation: Lipids in Health and Disease 2024 23:57
  36. Type 2 Diabetes (T2D) is influenced by genetic, environmental, and ageing factors. Ageing pathways exacerbate metabolic diseases. This study aimed to examine both clinical and genetic factors of T2D in older a...

    Authors: Siobhán O.’ Sullivan, Cynthia Al Hageh, Andreas Henschel, Stephanie Chacar, Antoine Abchee, Pierre Zalloua and Moni Nader
    Citation: Lipids in Health and Disease 2024 23:56
  37. Erectile dysfunction (ED) is closely associated with dyslipidemia; however, it is yet unknown how ED and remnant cholesterol (RC) are related. As such, this research sought to explore the correlation between R...

    Authors: Ke Huang, Shan Yin, Yunfei Xiao, Jiahao Wang, Jianwei Cui, Jia Wang and Yunjin Bai
    Citation: Lipids in Health and Disease 2024 23:55
  38. Dyslipidemias, including familial hypercholesterolemia (FH), are a significant risk factor for cardiovascular diseases. FH is a genetic disorder resulting in elevated levels of low-density lipoprotein choleste...

    Authors: Sophie Bouhour, Rosalie Plantefève, Virginie Gillet, Armita Abolghasemi, Fatima Zahra Bouchouirab, Andrea A. Baccarelli, Larissa Takser and Artuela Çaku
    Citation: Lipids in Health and Disease 2024 23:54
  39. The Triglyceride glucose-body mass index (TyG-BMI) and hemoglobin glycation index (HGI) are well-established surrogate markers for insulin resistance. Nevertheless, the extent to which these markers offer addi...

    Authors: Rupeng Wang, Ce Chen, Guiyu Xu and Zening Jin
    Citation: Lipids in Health and Disease 2024 23:53
  40. Type 2 diabetes mellitus (T2DM) is closely linked to metabolic syndrome, characterised by insulin resistance, hyperglycaemia, abnormal lipid metabolism, and chronic inflammation. Diabetic ulcers (DUs) comprise...

    Authors: Qi Tan, Qifeng He, Ze Peng, Xin Zeng, Yuzhe Liu, Dong Li, Shang Wang and Jianwei Wang
    Citation: Lipids in Health and Disease 2024 23:52
  41. Myocardial ischemia–reperfusion injury (MIRI) is widespread in the treatment of ischemic heart disease, and its treatment options are currently limited. Adiponectin (APN) is an adipocytokine with cardioprotect...

    Authors: Hongyi Yue, Qunhui Zhang, Senhao Chang, Xinjie Zhao, Mengjie Wang and Wenhua Li
    Citation: Lipids in Health and Disease 2024 23:51
  42. Steatotic liver disease poses a serious threat to human health and has emerged as one of the most significant burdens of chronic liver disease worldwide. Currently, the research mechanism is not clear, and the...

    Authors: Tiansu Lv, Yan Lou, Qianhua Yan, Lijuan Nie, Zhe Cheng and Xiqiao Zhou
    Citation: Lipids in Health and Disease 2024 23:50
  43. Genome-wide association studies (GWAS) have identified genetic variants linked to fat metabolism and related traits, but rarely pinpoint causative variants. This limitation arises from GWAS not considering fun...

    Authors: Casimiro Castillejo-López, José Ramón Bárcenas-Walls, Marco Cavalli, Anders Larsson and Claes Wadelius
    Citation: Lipids in Health and Disease 2024 23:48
  44. Being overweight or obese has become a serious public health concern, and accurate assessment of body composition is particularly important. More precise indicators of body fat composition include visceral adi...

    Authors: Jinci Mai, Qiulian Wu, Huanhua Wu, Chunyuan Zeng, Yingxin Li, Jingjie Shang, Biao Wu, Qijun Cai, Junbi Du and Jian Gong
    Citation: Lipids in Health and Disease 2024 23:47
  45. This study aims to investigate the prevalence of dyslipidemia and assess the joint association of physical activity (PA) and diet quality on dyslipidemia risk in urban areas of Xinjiang.

    Authors: Munire Mutalifu, Qian Zhao, Ying Wang, Xieyire Hamulati, Yu-Shan Wang, Lei Deng, Niyaziaili Adili, Fen Liu, Yi-Ning Yang and Xiao-Mei Li
    Citation: Lipids in Health and Disease 2024 23:46
  46. Remnant cholesterol (RC) represents a low-cost and readily measured lipid index that contributes significantly to residual cardiovascular disease risk. The triglyceride-glucose (TyG) index exhibits a significa...

    Authors: Xiaosheng Wu, Weiping Qiu, Houlin He, Guojun Zhao and Jianling Liu
    Citation: Lipids in Health and Disease 2024 23:45

Annual Journal Metrics

  • 2022 Citation Impact
    4.5 - 2-year Impact Factor
    4.9 - 5-year Impact Factor
    1.358 - SNIP (Source Normalized Impact per Paper)
    1.042 - SJR (SCImago Journal Rank)

    2023 Speed
    2 days submission to first editorial decision for all manuscripts (Median)
    68 days submission to accept (Median)

    2023 Usage 
    1,488 Altmetric mentions